Teva Pharmaceuticals USA, Inc Presence of Foreign Tablets/Capsules
Class II · Ongoing
Jan 25, 2026
Granules Pharmaceuticals Inc. Presence of Foreign Tablets/Capsules
Class II · Ongoing
Dec 18, 2025
Zydus Pharmaceuticals (USA) Inc Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).